A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
City of Hope Medical Center
Tempus AI
Incyte Corporation
Day One Biopharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc.
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Elevation Oncology
Stanford University
Novartis
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
ADC Therapeutics S.A.
Exelixis
Eli Lilly and Company
Pfizer
Rutgers, The State University of New Jersey
pharmaand GmbH
Hoffmann-La Roche
Genmab
Revolution Medicines, Inc.
Five Prime Therapeutics, Inc.
Gilead Sciences
Case Comprehensive Cancer Center
Stanford University
Hoffmann-La Roche
Pfizer
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
University of Kansas Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
GlaxoSmithKline
Amgen
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc
Verastem, Inc.